DK2010538T3 - Fremgangsmåde til fremstilling af [(1R), 2S]-2-aminopropionsyre 2-[4-(4-fluor-2-methyl-1H-indol-5-yloxy)-5-methylpyrrol]2,1-f-[1,2,4-triazin-6-yloxy]-1-methylethylester - Google Patents

Fremgangsmåde til fremstilling af [(1R), 2S]-2-aminopropionsyre 2-[4-(4-fluor-2-methyl-1H-indol-5-yloxy)-5-methylpyrrol]2,1-f-[1,2,4-triazin-6-yloxy]-1-methylethylester

Info

Publication number
DK2010538T3
DK2010538T3 DK07760872.7T DK07760872T DK2010538T3 DK 2010538 T3 DK2010538 T3 DK 2010538T3 DK 07760872 T DK07760872 T DK 07760872T DK 2010538 T3 DK2010538 T3 DK 2010538T3
Authority
DK
Denmark
Prior art keywords
yloxy
methylpyrrole
triazin
indol
fluoro
Prior art date
Application number
DK07760872.7T
Other languages
English (en)
Inventor
Gerard A Crispino
Mourad Hamedi
Thomas L Laporte
John E Thornton
Jaan A Pesti
Zhongmin Xu
Paul C Lobben
David K Leahy
Jale Muslehiddinoglu
Chiajen Lai
Robert P Discordia
Lori Ann Spangler
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38357966&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK2010538(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Application granted granted Critical
Publication of DK2010538T3 publication Critical patent/DK2010538T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Endocrinology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
DK07760872.7T 2006-04-21 2007-04-19 Fremgangsmåde til fremstilling af [(1R), 2S]-2-aminopropionsyre 2-[4-(4-fluor-2-methyl-1H-indol-5-yloxy)-5-methylpyrrol]2,1-f-[1,2,4-triazin-6-yloxy]-1-methylethylester DK2010538T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74530006P 2006-04-21 2006-04-21
PCT/US2007/066911 WO2007124332A1 (en) 2006-04-21 2007-04-19 PROCESS FOR THE PREPARATION OF [(1R), 2S]-2-AMINOPROPIONIC ACID 2-[4-(4-FLUORO-2-METHYL-1H-INDOL-5-YLOXY)-5-METHYLPYRROLO[2,1-f][1,2,4]TRIAZIN-6-YLOXY]-1-METHYLETHYL ESTER

Publications (1)

Publication Number Publication Date
DK2010538T3 true DK2010538T3 (da) 2013-03-18

Family

ID=38357966

Family Applications (1)

Application Number Title Priority Date Filing Date
DK07760872.7T DK2010538T3 (da) 2006-04-21 2007-04-19 Fremgangsmåde til fremstilling af [(1R), 2S]-2-aminopropionsyre 2-[4-(4-fluor-2-methyl-1H-indol-5-yloxy)-5-methylpyrrol]2,1-f-[1,2,4-triazin-6-yloxy]-1-methylethylester

Country Status (23)

Country Link
US (1) US7671199B2 (da)
EP (1) EP2010538B1 (da)
JP (1) JP5203353B2 (da)
KR (1) KR101423789B1 (da)
CN (1) CN101472927B (da)
AR (1) AR060622A1 (da)
AU (1) AU2007240453B2 (da)
BR (1) BRPI0710691A2 (da)
CA (1) CA2650059A1 (da)
CL (2) CL2007001141A1 (da)
DK (1) DK2010538T3 (da)
EA (1) EA019693B1 (da)
ES (1) ES2399379T3 (da)
HR (1) HRP20130099T1 (da)
IL (1) IL194715A (da)
MX (1) MX2008013232A (da)
NO (1) NO20084326L (da)
PE (1) PE20080193A1 (da)
PL (1) PL2010538T3 (da)
PT (1) PT2010538E (da)
SI (1) SI2010538T1 (da)
TW (1) TWI378100B (da)
WO (1) WO2007124332A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1928880A1 (en) * 2005-09-27 2008-06-11 Brystol-Myers Squibb Company Crystalline forms of [(1r), 2s]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester
US20120135875A1 (en) * 2008-02-29 2012-05-31 Bristol-Myers Squibb Company Methods for determining sensitivity to vascular endothelial growth factor receptor-2 modulators
AR074830A1 (es) 2008-12-19 2011-02-16 Cephalon Inc Pirrolotriazinas como inhibidores de alk y jak2
WO2020074863A1 (en) 2018-10-08 2020-04-16 Applied Photophysics Limited System and method for analysing the composition of a quenched flow reaction liquid

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6982265B1 (en) 1999-05-21 2006-01-03 Bristol Myers Squibb Company Pyrrolotriazine inhibitors of kinases
TWI272271B (en) 2002-07-19 2007-02-01 Bristol Myers Squibb Co Process for preparing certain pyrrolotriazine compounds
TWI329112B (en) * 2002-07-19 2010-08-21 Bristol Myers Squibb Co Novel inhibitors of kinases
US20050288290A1 (en) * 2004-06-28 2005-12-29 Borzilleri Robert M Fused heterocyclic kinase inhibitors
US7432373B2 (en) * 2004-06-28 2008-10-07 Bristol-Meyers Squibb Company Processes and intermediates useful for preparing fused heterocyclic kinase inhibitors
US7393667B2 (en) 2005-05-31 2008-07-01 Bristol-Myers Squibb Company Stereoselective reduction process for the preparation of pyrrolotriazine compounds
EP1928880A1 (en) 2005-09-27 2008-06-11 Brystol-Myers Squibb Company Crystalline forms of [(1r), 2s]-2-aminopropionic acid 2-[4-(4-fluoro-2-methyl-1h-indol-5-yloxy)-5-methylpyrrolo[2,1-f][1,2,4]triazin-6-yloxy]-1-methylethyl ester

Also Published As

Publication number Publication date
CA2650059A1 (en) 2007-11-01
CL2007001141A1 (es) 2008-01-18
AU2007240453A1 (en) 2007-11-01
EP2010538B1 (en) 2012-12-05
HRP20130099T1 (hr) 2013-03-31
PE20080193A1 (es) 2008-03-10
NO20084326L (no) 2008-11-18
EA200802171A1 (ru) 2009-08-28
TW200808799A (en) 2008-02-16
TWI378100B (en) 2012-12-01
CN101472927A (zh) 2009-07-01
BRPI0710691A2 (pt) 2011-08-23
US7671199B2 (en) 2010-03-02
AR060622A1 (es) 2008-07-02
CN101472927B (zh) 2012-07-04
EP2010538A1 (en) 2009-01-07
US20070249610A1 (en) 2007-10-25
IL194715A (en) 2013-10-31
WO2007124332A1 (en) 2007-11-01
MX2008013232A (es) 2008-10-21
SI2010538T1 (sl) 2013-06-28
EA019693B1 (ru) 2014-05-30
ES2399379T3 (es) 2013-04-01
PL2010538T3 (pl) 2013-04-30
KR20090008246A (ko) 2009-01-21
JP2009534413A (ja) 2009-09-24
JP5203353B2 (ja) 2013-06-05
CL2010000554A1 (es) 2010-10-15
AU2007240453B2 (en) 2012-04-12
PT2010538E (pt) 2013-02-22
KR101423789B1 (ko) 2014-07-30

Similar Documents

Publication Publication Date Title
DK2010496T3 (da) 4-anilinoquinolin-3-carbonsyreamider som CSF-1R-kinaseinhibitorer
DK2431359T3 (da) Fremgangsmåde til fremstilling af diaminophenothiaziniumforbindelser
DK2029524T3 (da) Fremgangsmåde til fremstilling af 2-[4-(3- og 2-fluorbenzyloxy)benzyl-amino]propanamider
DK2059513T3 (da) Fremgangsmåde til fremstillingen af 1,2,4-oxadiazolbenzoesyrer
EP1911738A4 (en) PHENOXYALKANSÄUREVERBINDUNG
ATE530523T1 (de) (3-amino-1,2,3,4-tetrahydro-9h-carbazol-9-yl)- essigsäurederivate
DK2086944T3 (da) Fremgangsmåde til fremstilling af difluormethylpyrazolylcarboxylater
DK2118090T3 (da) Fremgangsmåde til fremstilling af et benzimidazolderivat
IL196234A0 (en) A process for the preparation of optically active cyclopropylamines
IL185399A0 (en) Pyridyl acetic acid compounds
DK1910267T3 (da) Fremgangsmåde til fremstilling af carboxylsyrealkylestere
DK1745136T3 (da) Fremgangsmåde til enzymatisk fremstilling af (S)-3-cyano-5-methylhexansyre
FI20055616A0 (fi) Menetelmä valmisteen rakenteen muokkaamiseen
DK2489662T3 (da) Mellemprodukter af en ny fremgangsmåde til fremstillingen af 5-benzyliden-2-alkylimino-3-phenylthiazolidin-4-on derivater
DK1937671T3 (da) Benzimidazolthiophenforbindelser som PLK-inhibitorer
DK2029567T3 (da) Fremgangsmåde til frembringelse af benzopyran-2-ol-derivater
DK1756049T3 (da) Fremgangsmåde til fremstilling af 1,4-diphenylazetidinon-derivater
DK2213654T3 (da) Fremgangsmåde til fremstilling af 2-amino-5-brombenzamid derivater
BRPI0717826A2 (pt) Métodos para produzir um l-aminoácido, e para produzir um alquil-éster inferior de alfa-l-aspartil-l-fenil-alanina
ATE509925T1 (de) Substituierte bicyclocarbonsäureamidverbindungen
BRPI0817747A2 (pt) Processo para a preparação de derivados de ácido 2-di-halogenoacil-3-amino-acrílico
DK2020845T3 (da) Fremgangsmåde til høstning
DK2402306T3 (da) Fremgangsmåde til fremstilling af 5-aminolaevulinsyrehydrochlorid
NO344964B1 (no) Fremgangsmåte for fremstilling av et stabilt oksiderende biocid
DK2229062T3 (da) Fremgangsmåde til fremstillingen af et hydrolysat